Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167830 · ClinicalTrials.gov registry record · Phase 1
Barriers to Treatment in Obese Adolescents
A Phase 1 study of Obesity, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 292
- Enrollment target
- 1
- Study location
NCT00167830: Completed Phase 1 study of Obesity, sponsored by Virginia Commonwealth University.
NCT00167830 is a Phase 1 study of Obesity that has completed, run by Virginia Commonwealth University. The registered enrollment target is 292 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00167830, a Phase 1 study of Obesity, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 292 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify significant racial and ethnical differences in risk factors for development of obesity and weight loss in adolescents in Central Virginia
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Strength and Cardiovascular Conditioning
- BEHAVIORAL Food selection and portion control
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2003-11 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT00167830 record still lists
NCT00167830 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Motivational Interviewing is the first listed.
NCT00167830 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00167830 about?
NCT00167830 is a clinical study titled "Barriers to Treatment in Obese Adolescents". The purpose of this study is to identify significant racial and ethnical differences in risk factors for development of obesity and weight loss in adolescents in Central Virginia
What is the current status of trial NCT00167830?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 292 participants. The study started on 2003-11. Estimated completion is 2013-12.
What conditions does trial NCT00167830 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00167830?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Strength and Cardiovascular Conditioning (BEHAVIORAL), Food selection and portion control (BEHAVIORAL).
Who is sponsoring clinical trial NCT00167830?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167830 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00167830's enrollment target sits among peer trials
292 231st of 1053 higher than 822 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
RECRUITING · Phase 1
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
-
A Study of LY3971297 in Healthy Participants
RECRUITING · Phase 1
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- NCT05406622 · 292 participants · NA
MOTIV BTK Randomized Controlled Trial
- NCT05757102 · 292 participants · Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- NCT06569667 · 292 participants · NA
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia